COVID-19 can alter nearly every panel your doctor orders in a routine blood draw, from your white blood cell counts and liver enzymes to your blood sugar, clotting markers, and electrolytes. Some of these changes appear even in mild cases, while others track closely with disease severity. What makes this clinically tricky is that many of these abnormalities can persist for weeks or months after recovery, meaning blood work done well after you feel better may still look off.
How COVID-19 Changes Your Blood Cell Counts
A standard complete blood count, or CBC, is one of the most commonly ordered lab tests, and COVID-19 leaves clear fingerprints on it. The most consistent finding is a drop in lymphocytes, the white blood cells responsible for targeted immune defense. At the same time, neutrophils, which handle a more general first-response role, tend to rise. That shift creates a high neutrophil-to-lymphocyte ratio, which researchers have repeatedly found correlates with worse outcomes.
Beyond those two cell types, platelet counts tend to fall during active infection, as do hemoglobin, eosinophils, and basophils.1PubMed Central. Complete blood count alterations in COVID-19 patients: A narrative review In critical cases, low lymphocyte counts and low platelets become especially pronounced, and the ratio between neutrophils and lymphocytes climbs even higher.2PubMed Central. Neutrophil-Lymphocyte Ratio Predicting Case Severity in SARS-CoV-2 Infection: A Review If you had blood work during an active COVID-19 infection and your doctor flagged low lymphocytes or low platelets, the virus itself is the likely explanation.
One thing worth knowing: the lymphocyte drop is not always dramatic. Many mild cases show only a modest dip that stays within the lab’s normal reference range. The more severe the illness, the more pronounced the derangement. Hospitalized patients, particularly those in intensive care, tend to show the starkest abnormalities.
Inflammatory Markers Spike Across the Board
If your blood work includes C-reactive protein (CRP), ferritin, or an erythrocyte sedimentation rate (ESR), expect those to be elevated during active COVID-19. A large meta-analysis pooling data from dozens of studies found that patients with severe disease had substantially higher CRP, procalcitonin, ESR, and interleukin-6 levels compared to those with mild illness. Patients who ultimately died showed even larger elevations across all of these markers.3PubMed Central. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis
These are not obscure research-only tests. CRP and ESR are commonly ordered by primary care doctors to investigate everything from joint pain to unexplained fatigue. If either one comes back high during or shortly after COVID-19, the infection itself is the most probable cause. Ferritin, which is often checked as part of an iron workup, also jumps during COVID-19 because it doubles as an acute-phase reactant, meaning the body produces more of it during inflammation regardless of iron status. That distinction matters if you are being evaluated for anemia at the same time: a high ferritin in a COVID-19 patient does not necessarily mean your iron stores are fine.
Liver Function Tests
Liver enzymes are part of a standard metabolic panel, and COVID-19 pushes them out of range more often than you might expect. In one retrospective study, roughly 44% of COVID-19 patients had at least one abnormal liver function test.4PubMed Central. Liver function test abnormalities in COVID-19 patients and factors affecting them – a retrospective study The two main enzymes that go up are AST and ALT, both of which signal liver cell stress or damage. In that same study, patients with severe COVID-19 also had higher total bilirubin levels.
The causes are layered. SARS-CoV-2 can infect liver cells directly, but the immune system’s inflammatory response, oxygen deprivation from pneumonia, and medications used during treatment all contribute independently. A separate cross-sectional study found that higher AST and ALT levels in COVID-19 patients were each associated with worse prognoses.5Toxicology Reports. Liver enzymes as a predictor of mortality in patients with COVID-19? A cross-sectional study If your liver enzymes come back mildly elevated after a recent COVID-19 infection, the infection is a plausible and common explanation, though your doctor will want to confirm they normalize over the following weeks.
Kidney Function
Creatinine and estimated glomerular filtration rate (eGFR) are the workhorses of kidney assessment on a basic metabolic panel. COVID-19 can push creatinine up and eGFR down, reflecting reduced kidney filtering capacity. A prospective study found that COVID-19 patients had significantly higher serum creatinine and cystatin C levels and significantly lower eGFR compared to healthy controls. Among hospitalized patients, those in intensive care showed the deepest kidney impairment.6PubMed Central. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study
The encouraging part of that same study was that in the group of patients treated outside the ICU, creatinine fell and eGFR rose during the course of treatment, suggesting the kidney stress was reversible in less severe cases. ICU patients, on the other hand, saw their kidney function continue to worsen. If you already have chronic kidney disease and catch COVID-19, the infection could temporarily amplify your lab abnormalities, making it look like your kidney disease has progressed when the real culprit is the acute infection.
Blood Sugar, Cholesterol, and Metabolic Shifts
COVID-19 does not just cause short-term spikes in blood sugar during the fever-and-cough phase. Research has shown that the virus triggers new insulin resistance, meaning the body’s cells become less responsive to insulin even in people who were metabolically healthy before. In one study, blood glucose, insulin levels, and a standard measure of insulin resistance were all elevated during active infection and, strikingly, remained elevated into the recovery phase. Triglycerides went up while HDL cholesterol, the so-called “good” cholesterol, dropped. Total cholesterol and LDL cholesterol were modestly reduced.7PubMed Central. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors
A separate study comparing lipid profiles of people admitted with moderate-to-severe COVID-19 against diabetic and healthy controls found a similar pattern: total cholesterol, LDL, and HDL were lower in the COVID-19 group, while triglycerides and the triglyceride-to-HDL ratio were higher. Fasting blood glucose and HbA1c, a measure of average blood sugar over the prior two to three months, were also significantly higher in the COVID-19 group compared to healthy controls.8Scientific Reports. Metabolic implications of COVID-19 with a focus on lipid profiles and inflammatory markers
This matters practically. If you get a lipid panel or glucose check within a few months of a COVID-19 infection and your triglycerides look higher than usual or your blood sugar is creeping up, the infection itself could be distorting the results. Your doctor may want to recheck those values after more recovery time before making medication decisions.
Clotting Markers and D-Dimer
D-dimer is a protein fragment produced when blood clots break down. It is not always part of a routine panel, but doctors frequently order it when evaluating for blood clots or during COVID-19 workups. Elevated D-dimer became one of the hallmark lab findings of COVID-19, and what surprised clinicians was how long it could stay elevated after the infection resolved.
One study measured D-dimer levels at a median of about 94 days after COVID-19 diagnosis and found that roughly 15% of recovered patients still had elevated levels. Among those with persistent elevation, imaging confirmed a pulmonary embolism in one patient and chronic thromboembolic pulmonary hypertension in another.9PubMed Central. Impact of persistent D-dimer elevation following recovery from COVID-19 A separate study found a similar rate, with about 16% of patients showing elevated D-dimer at an average of 118 days after diagnosis.10Austin Anesthesiology. Long-term D-Dimer Elevation Post-COVID-19: It s Significance in Thrombotic Complications Following Joint Replacement Surgeries
Beyond D-dimer, fibrinogen levels also tend to climb during and after COVID-19, and in some patients the elevation persists for more than two months post-recovery.11The Ukrainian Biochemical Journal. Markers of prothrombotic state of patients recovered after COVID-19 If you are having surgery or being evaluated for a clotting condition and recently had COVID-19, mention it so your doctor can interpret elevated clotting markers in context rather than launching an unnecessary workup.
Electrolyte Disturbances
Electrolytes are checked on nearly every basic metabolic panel, and COVID-19 can throw several of them off. Potassium gets the most attention. In one study of 290 hospitalized patients, 41% developed low potassium during their stay, with most cases falling into the mild range. Half of the patients with low potassium also had low calcium. Increased urinary potassium loss appeared to drive the depletion in most cases.12PubMed Central. Hypokalemia in Patients with COVID-19
Sodium and magnesium are also commonly affected. A study of patients without pre-existing conditions found that 38% had low sodium and 32% had low magnesium on admission, with those who ended up in intensive care showing more pronounced sodium and magnesium derangements.13PubMed Central. Evaluation of electrolyte status of sodium, potassium and magnesium, and fasting blood sugar at the initial admission of individuals with COVID-19 without underlying disease in Golestan Hospital, Kermanshah A separate large study of 600 ICU patients found that unfavorable outcomes were associated with higher-than-normal sodium, potassium, and phosphorus alongside lower calcium at admission.14The Egyptian Journal of Bronchology. Electrolyte profile in COVID-19 patients: insights into outcomes
The mechanisms behind these shifts involve the virus’s interaction with the renin-angiotensin system, which regulates fluid and electrolyte balance, as well as fever-related losses, poor oral intake during illness, and medication effects. Mild electrolyte abnormalities typically self-correct as you recover.
Heart and Muscle Enzymes
Troponin, creatine kinase (CK), and lactate dehydrogenase (LDH) are ordered when doctors suspect heart or muscle damage. All three can rise during COVID-19. A study comparing cardiac patients with and without COVID-19 found that those with the virus had significantly higher CK and LDH levels and were far more likely to test positive for troponin, about 71% versus 41% in non-COVID cardiac patients.15Journal of Advances in Medical and Biomedical Sciences. Serum Lactate Dehydrogenase, Creatinine Phosphokinase, and Troponin Levels Among Cardiac Patients with Coronavirus Disease 2019: A Retrospective Study
CK and LDH elevations are not exclusive to people with heart conditions. Research into long COVID found that CK and LDH remained elevated in some recovered patients and correlated with depression severity scores.16Archives of Neuroscience. Neuropathology of Severe Depression in Long COVID-19 Infection; Possible Roles for Astrocytes, Creatine Kinase and Lactate Dehydrogenase Activity That is a reminder that elevated muscle enzymes after COVID-19 do not automatically mean your heart is in trouble. Systemic inflammation and skeletal muscle involvement can produce similar lab patterns.
Iron and Ferritin
Iron metabolism gets disrupted during COVID-19 in a way that can be confusing on paper. Serum iron and transferrin saturation both drop during infection, which looks like iron deficiency. But ferritin, the body’s iron storage marker, goes in the opposite direction, climbing higher as disease severity increases. In one study, elevated ferritin levels increased the odds of severe and critical disease by roughly six- to eightfold compared to controls.17PubMed Central. Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection Hemoglobin also fell across all severity groups in that study.
This creates a paradox: you have low circulating iron alongside high ferritin, which in any other context might look contradictory. The explanation is that inflammation causes the body to lock iron away inside cells, pulling it out of circulation. This is actually a defense mechanism, as many pathogens need free iron to replicate. But on a lab report, it can mislead both patients and clinicians. If your iron studies after COVID-19 show high ferritin with low serum iron, that pattern points to inflammation-driven iron redistribution rather than iron overload.
Thyroid Function
Thyroid function tests are not part of every routine panel, but many people have them checked regularly, and COVID-19 can scramble the results. A study examining thyroid tests on admission found that only about 15% of COVID-19 patients had completely normal results. The rest showed various degrees of thyroid dysfunction: roughly a third had subclinical hyperthyroidism, over a third had overt hyperthyroidism, and smaller fractions had hypothyroidism or subclinical hypothyroidism.18The Egyptian Journal of Bronchology. Impact of Covid-19 infection on thyroid functions
Much of this is thought to reflect “sick euthyroid syndrome,” where severe illness temporarily alters thyroid hormone levels without indicating true thyroid disease. The practical takeaway: if your thyroid labs looked off during or soon after COVID-19, your doctor should recheck them once you have fully recovered before changing any thyroid medication.
How Long Do These Changes Last
For most people with mild to moderate infections, the majority of lab abnormalities resolve within a few weeks to a couple of months. But a meaningful subset of patients have persistent changes. One study found that about 12% of patients still had low lymphocyte counts at a median follow-up of 70 days, and that lymphopenia was still detectable in 14% of patients tested between 80 and 102 days post-diagnosis.19Scientific Reports. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19
Long COVID, broadly defined as symptoms lasting at least a few months after infection, affects an estimated 10% or more of people who catch the virus, and its laboratory picture is diffuse. Sustained hematological changes including anemia, persistent lymphopenia, and ongoing elevations of ferritin, D-dimer, and interleukin-6 have been reported in long COVID patients.20PubMed Central. Hematological alterations associated with long COVID-19 The challenge is that no single blood test reliably diagnoses long COVID. The biomarkers identified so far, ranging from inflammatory proteins to hormonal shifts to clotting abnormalities, appear in some patients but not others.21PubMed Central. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Autoimmune Markers After Infection
One of the more unsettling lab findings associated with COVID-19 is a rise in autoantibodies, immune proteins that mistakenly target the body’s own tissues. A study comparing COVID-19 patients to healthy controls found that antinuclear antibodies (ANAs), the general screening marker for autoimmune diseases, were positive in roughly 40 to 49% of COVID-19 patients across different testing methods, representing about a 2.5-fold increase over control rates.22PubMed Central. Prevalence of anti-nuclear antibodies in COVID-19 patients: a remarkable 2.5-fold rise compared to healthy controls
A positive ANA test does not mean you have lupus or another autoimmune condition. ANAs can appear transiently after many viral infections. But the sheer frequency of ANA positivity in COVID-19 patients raises questions about whether the virus is seeding longer-term autoimmune risk in some people. If you have a positive ANA drawn during or after COVID-19, your doctor will likely want to retest after several months and look for symptoms before jumping to a diagnosis.
Can COVID-19 Vaccines Affect Blood Work
Vaccines are not the same as infection, and their effects on blood work are far milder. A large nested case-control study found a modest increase in leukopenia, a temporary dip in white blood cell counts, after the second dose of the Pfizer-BioNTech vaccine, but no increased risk of any blood abnormalities after the CoronaVac (inactivated virus) vaccine.23PubMed Central. COVID-19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study A separate study of patients on clozapine, a medication requiring regular blood monitoring because it can cause dangerous drops in white cells, found that mRNA vaccination caused only mild and transient leukopenia or neutropenia in a small percentage. No serious hematological side effects were observed.24Exploratory Research in Clinical and Social Pharmacy. Impact of mRNA COVID-19 vaccination on hematological parameters in patients maintained on clozapine: A retrospective study from Qatar
The bottom line on vaccines and blood work: if you are scheduled for routine labs, getting vaccinated a day or two before the draw could theoretically produce a mild and short-lived dip in white blood cells, but it is unlikely to be clinically significant. It is nowhere near the scale of changes seen with actual infection.
Pediatric Differences
Children’s blood work during COVID-19 does not always mirror what adults experience. While kids can show similar inflammatory marker elevations, the more dramatic lab derangements tend to appear in multisystem inflammatory syndrome in children, or MIS-C, a rare but serious complication that occurs weeks after infection. Research has found that a vascular growth factor called VEGF-D rises significantly in children with COVID-19 and reaches its highest levels in MIS-C and severe cases.25PubMed Central. Diagnostic performance of vascular endothelial growth factor D in severity stratification of pediatric COVID-19 and multisystem inflammatory syndrome in children Children with MIS-C can have dramatic inflammatory marker spikes, extremely high ferritin, and abnormal cardiac enzymes that look alarming on a standard lab panel. These tend to resolve with treatment, but the initial presentation can send blood work results far outside normal pediatric ranges.
Long-Term Micronutrient Depletion
Perhaps the most surprising finding for people who think of COVID-19 as “done” once they feel better is evidence that the infection may increase your risk of developing micronutrient deficiencies years later. A large matched cohort study of people with type 2 diabetes followed over up to five years found that those who had COVID-19 faced a roughly 80% higher risk of developing vitamin D deficiency, a 56% higher risk of vitamin B12 deficiency, and a 77% higher risk of magnesium deficiency compared to matched controls without COVID-19.26PubMed Central. COVID-19 and long-term risk of incident laboratory-defined micronutrient deficiency in patients with type 2 diabetes: a multicenter propensity score–matched cohort study
This study was conducted in a diabetic population, so the findings may not generalize perfectly to everyone. But the magnitude of the increased risk is notable and suggests that COVID-19 may create lasting metabolic disruptions that only become apparent on later blood work. If you have had COVID-19 and your routine labs start showing borderline-low vitamin D or magnesium months or years later, the infection could be a contributing factor worth discussing with your doctor.